Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...
The US Food and Drug Administration has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus continuous glucose monitors to Class I, the highest level of urgency. The recall, which ...
Feb. 4 (UPI) --Officials for Abbott Diabetes Care have recalled some of the company's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors for people with diabetes. The Food ...
Abbott received a warning letter from the Food and Drug Administration related to its FreeStyle Libre continuous glucose monitors. The warning letter, dated Jan. 23 and posted to the FDA’s website on ...
Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...
Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors. In December 2025, FDA posted an early alert that Abbott Diabetes Care was ...
Health care technology company Abbott has recalled certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems because the sensors are displaying incorrect glucose ...
(AP Photo/Jacquelyn Martin, File) (Jacquelyn Martin, Copyright 2018 The Associated Press. All rights reserved.) A voluntary recall has been issued for certain glucose ...
The U.S. Food and Drug Administration (FDA) on Wednesday categorized a product recall initiated by Abbott Laboratories (ABT) affecting certain lots of its glucose monitor sensors as the most serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results